Not content with taking on the respiratory syncytial virus (RSV) prevention market with its antibody-based therapy Beyfortus, AstraZeneca has agreed to buy US biotech Icosavax and its phase 3 ...

The Oxford-AstraZeneca Covid vaccine is being withdrawn worldwide, the company has said, months after the pharmaceutical firm ...

It paid off approximately $7 billion in debt and grew its pipeline through strategic acquisitions, such as Fusion, Icosavax, and Amolyt. AstraZeneca PLC (NASDAQ:AZN) expects overall sales to grow ...